HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 191 filers reported holding HAEMONETICS CORP in Q1 2014. The put-call ratio across all filers is 3.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $151,464 | +79.1% | 1,779 | +65.5% | 0.01% | +66.7% |
| Q4 2022 | $84,549 | -95.1% | 1,075 | -96.7% | 0.01% | -95.7% |
| Q4 2021 | $1,725,000 | +226.7% | 32,535 | +582.9% | 0.14% | +180.0% |
| Q1 2021 | $528,000 | -76.6% | 4,764 | -75.8% | 0.05% | -77.7% |
| Q4 2019 | $2,260,000 | +161.9% | 19,676 | +99.3% | 0.22% | +173.2% |
| Q1 2019 | $863,000 | +323.0% | 9,875 | +382.6% | 0.08% | +310.0% |
| Q4 2018 | $204,000 | +374.4% | 2,046 | +439.8% | 0.02% | +566.7% |
| Q3 2018 | $43,000 | -97.8% | 379 | -98.2% | 0.00% | -97.7% |
| Q2 2018 | $1,916,000 | +1047.3% | 21,375 | +312.6% | 0.13% | +348.3% |
| Q3 2015 | $167,000 | +3240.0% | 5,181 | +3795.5% | 0.03% | +2800.0% |
| Q1 2015 | $5,000 | -97.4% | 133 | -97.8% | 0.00% | -97.8% |
| Q1 2014 | $195,000 | +4775.0% | 6,000 | +5900.0% | 0.05% | +2200.0% |
| Q4 2013 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |